| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.042 | 0.5 |